![Filip Borgions](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Filip Borgions
Hoofd Techniek/Wetenschap/O&O bij
ARGENX SE
Profiel
Filip Borgions currently works at argenx SE, as Chief Technology Innovation Officer.
Dr. Borgions also formerly worked at Thrombogenics, Inc., as Principal.
Dr. Borgions received his undergraduate degree and doctorate degree from Katholieke Universiteit Leuven.
Actieve functies van Filip Borgions
| Bedrijven | Functie | Begin |
|---|---|---|
| ARGENX SE | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Eerdere bekende functies van Filip Borgions
| Bedrijven | Functie | Einde |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Corporate Officer/Principal | - |
Opleiding van Filip Borgions
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
